Global Cancer Diagnostics Device Market 2016-2020 - New Market Report

An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options.
The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.
Technavio's analysts forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

Full Report Details at
- http://www.fastmr.com/prod/1194176_global_cancer_diagnostics.aspx?afid=301

Covered in this report
The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.

The market is divided into the following segments based on geography:

* Americas
* APAC
* EMEA

Technavio's report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* Abbott Diagnostics
* Agilent Technologies
* BD
* bioMerieux
* Qiagen
* Roche Diagnostics

Other prominent vendors

* Affymetrix
* Ambry Genetics
* Annoroad
* Aviva Biosciences
* Biochain
* Bio-Rad
* Cancer Genetics
* Cepheid
* CompanionDx
* DiagnoCure
* Epic Sciences
* Epigenomics
* Genomic Health
* HalioDX
* Hologic
* Illumina
* Myriad Genetics
* Thermo Fisher Scientific
* Ventana Medical Systems
* Vysis

Market driver

* Demand for personalized medicines
* For a full, detailed list, view our report

Market challenge

* High cost of developing companion diagnostics
* For a full, detailed list, view our report

Market trend

* Demand for personalized medicines
* For a full, detailed list, view our report

Key questions answered in this report

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)